在纤维炎性皮肤疾病中,EGFR-STAT1通路驱动纤维化发作
Anahi V Odell1,2, Nathan M Newton1,2,3, Anna Eisenstein1
1Department of Dermatology, Yale University School of Medicine, New Haven, CT, USA.
Nature communications
|October 9, 2025
概括
由EGFR驱动的纤维细胞STAT1信号传递对于慢性炎症性皮肤疾病中的皮肤纤维化至关重要. 抑制这种途径为这些难以治疗的疾病提供了潜在的治疗策略.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 慢性炎症性皮肤疾病,特别是那些涉及纤维化疾病,存在重大治疗挑战.
- 在皮肤炎症中决定纤维化进展的分子信号在很大程度上仍未被阐明.
研究的目的:
- 研究慢性炎症性皮肤疾病中纤维化背后的分子机制.
- 为了确定关键的信号通路和细胞组件参与纤维化皮肤疾病的发病.
主要方法:
- 一个单细胞RNA测序图谱 (scRNA-seq) 的生成,将七种炎症性皮肤疾病与健康对照进行比较.
- 使用小鼠模型进行体内研究,以评估纤维细胞STAT1在皮肤纤维化中的作用.
- 研究EGFR,STAT1和纤维化基因表达之间的相互作用.
主要成果:
- 纤维化皮肤疾病在纤维细胞中表现出增加的STAT1表达和活性.
- 纤维细胞特异性STAT1对于小鼠皮肤纤维化发展至关重要.
- EGFR以独立于JAK的方式直接激活STAT1,促进纤维化基因表达特征.
- 来自状细胞的EGFR连体刺激EGFR-STAT1通路,这表明它在纤维化中起着作用.
结论:
- 纤维细胞中的EGFR-STAT1信号轴是纤维炎性皮肤疾病中纤维性基因表达的关键媒介.
- 这项研究揭示了STAT1在驱动纤维化皮肤疾病中的干扰素独立功能.
- 向EGFR-STAT1通路为耐火性纤维性皮肤疾病提供了潜在的治疗途径.
相关概念视频
The JAK-STAT Signaling Pathway
12.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
12.0K
Intracellular Signaling Affects Focal Adhesions
3.5K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
3.5K
TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
MAPK Signaling Cascades
7.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.9K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.6K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.6K
Introduction to Fibroblasts
3.8K
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.8K


